) has been revised to $7.65 / share. This is a decrease of 14.29% from the prior estimate of $8.92 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...
) has been revised to $8.92 / share. This is a decrease of 27.08% from the prior estimate of $12.24 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...
HINGHAM, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical ...
Allison Rosefort, a MedTech and healthcare marketing leader with a track record of successfully launching and managing product lifecycles, has joined Microbot Medical ® as Vice President of Marketing.
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results